Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Mycosis Fungoides × Light × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Dermatologic 1

Conditions

Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1

Interventions

Peripheral Blood Stem Cell Transplantation 32 fludarabine phosphate 31 Cyclophosphamide 30 Mycophenolic Acid 24 Whole-Body Irradiation 22 Cyclosporine 21 Tacrolimus 18 Radiotherapy 18 Methotrexate 15 Antilymphocyte Serum 14 Flow Cytometry 13 Etoposide 13 Busulfan 13 Filgrastim 12 Vorinostat 11 Bexarotene 11 Lenalidomide 10 Bortezomib 10 mogamulizumab 9 Melphalan 9 Therapeutics 8 Psychiatric Rehabilitation 8 Methylprednisolone 8 Brentuximab Vedotin 8 romidepsin 7 pembrolizumab 7 fludarabine 7 Rituximab 7 Polymerase Chain Reaction 7 Magnetic Resonance Spectroscopy 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05872854 2026-02-09

RW-HPN-MF-01

Abramson Cancer Center at Penn Medicine

Phase 2 Completed

DermatologicLymphoid

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡